Cambridge Investment Research Advisors’s iShares Morningstar Mid-Cap Value ETF IMCV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.93M | Buy |
58,208
+7,630
| +15% | +$656K | 0.01% | 975 |
|
|
2025
Q4 | $4.16M | Buy |
50,578
+163
| +0.3% | +$13.2K | 0.01% | 1026 |
|
|
2025
Q3 | $4.05M | Buy |
50,415
+6,525
| +15% | +$513K | 0.01% | 1033 |
|
|
2025
Q2 | $3.33M | Buy |
43,890
+37,187
| +555% | +$2.71M | 0.01% | 1087 |
|
|
2025
Q1 | $497K | Buy |
6,703
+522
| +8% | +$39.3K | ﹤0.01% | 2441 |
|
|
2024
Q4 | $459K | Buy |
6,181
+47
| +0.8% | +$3.63K | ﹤0.01% | 2499 |
|
|
2024
Q3 | $470K | Sell |
6,134
-113
| -2% | -$8.32K | ﹤0.01% | 2463 |
|
|
2024
Q2 | $439K | Sell |
6,247
-666
| -10% | -$47.1K | ﹤0.01% | 2396 |
|
|
2024
Q1 | $502K | Buy |
6,913
+921
| +15% | +$62.9K | ﹤0.01% | 2272 |
|
|
2023
Q4 | $406K | Buy |
5,992
+33
| +0.6% | +$2.05K | ﹤0.01% | 2360 |
|
|
2023
Q3 | $361K | Sell |
5,959
-2,636
| -31% | -$168K | ﹤0.01% | 2360 |
|
|
2023
Q2 | $548K | Sell |
8,595
-364
| -4% | -$22.3K | ﹤0.01% | 2061 |
|
|
2023
Q1 | $554K | Buy |
8,959
+1,735
| +24% | +$111K | ﹤0.01% | 2017 |
|
|
2022
Q4 | $448K | Buy |
7,224
+177
| +3% | +$10.9K | ﹤0.01% | 2101 |
|
|
2022
Q3 | $394K | Sell |
7,047
-8,636
| -55% | -$536K | ﹤0.01% | 2132 |
|
|
2022
Q2 | $931K | Sell |
15,683
-258
| -2% | -$16.8K | 0.01% | 1530 |
|
|
2022
Q1 | $1.1M | Sell |
15,941
-4,505
| -22% | -$304K | 0.01% | 1509 |
|
|
2021
Q4 | $1.4M | Buy |
20,446
+5,451
| +36% | +$362K | 0.01% | 1366 |
|
|
2021
Q3 | $948K | Sell |
14,995
-140
| -0.9% | -$8.99K | ﹤0.01% | 1575 |
|
|
2021
Q2 | $972K | Sell |
15,135
-954
| -6% | -$61.5K | ﹤0.01% | 1554 |
|
|
2021
Q1 | $989K | Buy |
16,089
+309
| +2% | +$17.8K | 0.01% | 1440 |
|
|
2020
Q4 | $823K | Sell |
15,780
-837
| -5% | -$40.9K | ﹤0.01% | 1429 |
|
|
2020
Q3 | $726K | Buy |
16,617
+78
| +0.5% | +$3.44K | ﹤0.01% | 1371 |
|
|
2020
Q2 | $696K | Buy |
16,539
+33
| +0.2% | +$1.32K | 0.01% | 1348 |
|
|
2020
Q1 | $588K | Sell |
16,506
-12,351
| -43% | -$611K | 0.01% | 1274 |
|
|
2019
Q4 | $1.62M | Sell |
28,857
-531
| -2% | -$28.9K | 0.01% | 888 |
|
|
2019
Q3 | $1.58M | Buy |
29,388
+78
| +0.3% | +$4.09K | 0.01% | 849 |
|
|
2019
Q2 | $1.54M | Buy |
29,310
+4,917
| +20% | +$256K | 0.01% | 818 |
|
|
2019
Q1 | $1.27M | Buy |
24,393
+3,756
| +18% | +$191K | 0.01% | 917 |
|
|
2018
Q4 | $955K | Buy |
20,637
+66
| +0.3% | +$3.35K | 0.01% | 950 |
|
|
2018
Q3 | $1.11M | Sell |
20,571
-69
| -0.3% | -$3.75K | 0.01% | 966 |
|
|
2018
Q2 | $1.09M | Sell |
20,640
-270
| -1% | -$14.3K | 0.01% | 926 |
|
|
2018
Q1 | $1.09M | Buy |
20,910
+888
| +4% | +$47.4K | 0.01% | 896 |
|
|
2017
Q4 | $1.06M | Buy |
20,022
+12,684
| +173% | +$653K | 0.01% | 867 |
|
|
2017
Q3 | $370K | Buy |
7,338
+978
| +15% | +$48.3K | 0.01% | 1431 |
|
|
2017
Q2 | $314K | Sell |
6,360
-7,749
| -55% | -$381K | ﹤0.01% | 1479 |
|
|
2017
Q1 | $698K | Buy |
14,109
+1,920
| +16% | +$94.7K | 0.01% | 906 |
|
|
2016
Q4 | $587K | Buy |
+12,189
| New | +$564K | 0.01% | 939 |
|
|
2015
Q3 | – | Sell |
-15,996
| Closed | -$659K | – | 1535 |
|
|
2015
Q2 | $659K | Buy |
15,996
+480
| +3% | +$20.3K | 0.02% | 679 |
|
|
2015
Q1 | $653K | Sell |
15,516
-885
| -5% | -$36.9K | 0.02% | 671 |
|
|
2014
Q4 | $681K | Buy |
16,401
+435
| +3% | +$17.6K | 0.02% | 628 |
|
|
2014
Q3 | $637K | Buy |
+15,966
| New | +$654K | 0.02% | 694 |
|
Other funds holding IMCV
VIA
OWM
EH
Cambridge Investment Research Advisors's IMCV Position: Q1 2026 in Review
Cambridge Investment Research Advisors increased its iShares Morningstar Mid-Cap Value ETF (IMCV) stake by 15% in Q1 2026, buying an estimated $656K and bringing the position to 58,208 shares worth $4.93M. The position accounts for 0.01% of the portfolio, ranked #975.
Cambridge Investment Research Advisors first reported a position in IMCV in Q3 2014 and has held it in 42 quarters since. 172 funds tracked by Wall St. Rank hold IMCV as of Q1 2026.
- Cambridge Investment Research Advisors held 58,208 shares of iShares Morningstar Mid-Cap Value ETF worth $4.93M as of Q1 2026.
- Cambridge Investment Research Advisors bought 7,630 iShares Morningstar Mid-Cap Value ETF shares in Q1 2026, an estimated $656K.
- iShares Morningstar Mid-Cap Value ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #975 holding.
- Cambridge Investment Research Advisors first reported a position in iShares Morningstar Mid-Cap Value ETF in Q3 2014 and has held it in 42 quarters since.
- 172 funds tracked by Wall St. Rank held iShares Morningstar Mid-Cap Value ETF as of Q1 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.